The EESC issues between 160 and 190 opinions and information reports a year.
It also organises several annual initiatives and events with a focus on civil society and citizens’ participation such as the Civil Society Prize, the Civil Society Days, the Your Europe, Your Say youth plenary and the ECI Day.
The EESC brings together representatives from all areas of organised civil society, who give their independent advice on EU policies and legislation. The EESC's326 Members are organised into three groups: Employers, Workers and Various Interests.
The EESC has six sections, specialising in concrete topics of relevance to the citizens of the European Union, ranging from social to economic affairs, energy, environment, external relations or the internal market.
The EESC notes that certain standards are not fully aligned with EU requirements, particularly those relating to the isolation distance for certified seed for sorghum, which are lower, the varietal purity of parental lines used for the production of seeds for hybrids of maize, and the content of seeds of other species for certified seed for maize.
The EESC agrees with the legislative proposal under examination, subject, however to first obtaining the necessary guarantees showing that the limitations indicated in the audit report have been remedied, that production standards in Ukraine now comply strictly with European requirements and that an absence of unfair competition can be guaranteed.
Ukrainian producers have access to certain substances that are banned in the European Union. These divergences lead to a distortion of competition and would result in products which do not comply with EU health and environmental standards being able to enter the territory of the European Union.
The most significant differences include access to active weed control substances such as atrazine (banned in the EU since 2003) or acetochlor (banned in the EU since 2012).
With regard to pest protection, Ukrainian producers still have access to active substances in the neonicotinoid family, some of which are banned in the EU, such as clothianidin, thiamethoxam or very soon thiacloprid.